Exact Mass: 488.1431
Exact Mass Matches: 488.1431
Found 500 metabolites which its exact mass value is equals to given mass value 488.1431
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Citicoline
CDP-choline is a member of the class of phosphocholines that is the chloine ester of CDP. It is an intermediate obtained in the biosynthetic pathway of structural phospholipids in cell membranes. It has a role as a human metabolite, a psychotropic drug, a neuroprotective agent, a Saccharomyces cerevisiae metabolite and a mouse metabolite. It is a member of phosphocholines and a member of nucleotide-(amino alcohol)s. It is functionally related to a CDP. It is a conjugate base of a CDP-choline(1+). Citicoline is a donor of choline in biosynthesis of choline-containing phosphoglycerides. It has been investigated for the treatment, supportive care, and diagnosis of Mania, Stroke, Hypomania, Cocaine Abuse, and Bipolar Disorder, among others. Citicoline is a nutritional supplement and source of choline and cytidine with potential neuroprotective and nootropic activity. Citicoline, also known as cytidine-5-diphosphocholine or CDP-choline, is hydrolyzed into cytidine and choline in the intestine. Following absorption, both cytidine and choline are dispersed, utilized in various biosynthesis pathways, and cross the blood-brain barrier for resynthesis into citicoline in the brain, which is the rate-limiting product in the synthesis of phosphatidylcholine. This agent also increases acetylcholine (Ach), norepinephrine (NE) and dopamine levels in the central nervous system (CNS). In addition, citicoline is involved in the preservation of sphingomyelin and cardiolipin and the restoration of Na+/K+-ATPase activity. Citicoline also increases glutathione synthesis and glutathione reductase activity, and exerts antiapoptotic effects. Donor of choline in biosynthesis of choline-containing phosphoglycerides. N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics Acquisition and generation of the data is financially supported in part by CREST/JST. D002491 - Central Nervous System Agents > D018697 - Nootropic Agents Citicoline (Cytidine diphosphate-choline) is an intermediate in the synthesis of phosphatidylcholine, a component of cell membranes. Citicoline exerts neuroprotective effects. Citicoline (Cytidine diphosphate-choline) is an intermediate in the synthesis of phosphatidylcholine, a component of cell membranes. Citicoline exerts neuroprotective effects.
Dracorubin
A proanthocyanidin isolated from Dracaena draco.
beta-D-Glcp-(1->4)-alpha-L-Rhap-(1->3)-D-Glcp
6'-O-Acetylglycitin
Glycitein 7-(6-O-acetyl-beta-D-glucoside) is a glycosyloxyisoflavone that is glycitin carrying an acetyl substituent at position 6 on the glucose moiety. It has a role as a plant metabolite. It is an acetate ester, a glycosyloxyisoflavone, a hydroxyisoflavone, a methoxyisoflavone, a monosaccharide derivative, a beta-D-glucoside and an O-acyl carbohydrate. It is functionally related to a glycitin. 6-O-Acetylglycitin is a natural product found in Glycine and Glycine max with data available. Present in soya foods; potential nutriceutical. 6-Acetylglycitin is found in many foods, some of which are soy sauce, soy milk, soy yogurt, and other soy product. 6-O-Acetylglycitin is found in miso. 6-O-Acetylglycitin is present in soya foods; potential nutriceutical. 6''-O-Acetylglycitin, a acetyl glucoside, is one of the isoflavone isomer in soybeans, shows various extents of content reduction dependent on storage temperature, packaging condition, and its isoflavone isomer kind[1]. 6''-O-Acetylglycitin, a acetyl glucoside, is one of the isoflavone isomer in soybeans, shows various extents of content reduction dependent on storage temperature, packaging condition, and its isoflavone isomer kind[1].
3-Fucosyllactose
3-Fucosyllactose is a milk oligosaccharide isolated in 1958 (PMID: 13546862), and that was also isolated for the first time from the urine of a blood group O, nonsecretor, woman during pregnancy and lactation in 1977 (PMID: 838696). Is resistant to enzymic hydrolysis in the gastrointestinal tract of the infant; it is postulated that they reach the large intestine where they serve as substrates for bacterial metabolism. (PMID 10837303). 3-Fucosyllactose is a milk oligosaccharide isolated in 1958 (PMID: 13546862), and that was also isolated for the first time from the urine of a blood group O, nonsecretor, woman during pregnancy and lactation in 1977 (PMID: 838696)
Bisosthenon B
Bisosthenon B is found in citrus. Bisosthenon B is a constituent of Citrus paradisi (grapefruit)
2-Fucosyllactose
2-Fucosyllactose (Fuc-a( 1->2)Galb(1->4)Glc) is an oligosaccharide first found in milk in the 1950s, and a well established isolation technique was found in 1972 (PMID: 5012321). It has been used as an acceptor substrate in assays of the blood group A and B gene specified glycosyltransferases since. (PMID 6894927). 2'-Fucosyllactose (2'-FL) is an oligosaccharide that could be derived from human milk. 2'-Fucosyllactose regulates the expression of CD14, alleviates colitis and regulates the gut microbiome. 2'-Fucosyllactose stimulates T cells to increase IFN-γ production and decreases IL-6, IL-17, and TNF-α production of cytokines[1][2].
Khelmarin D
Khelmarin D is found in citrus. Khelmarin D is a constituent of a cross hybrid of Citrus paradisi and Citrus tangerina (Rutaceae). Constituent of a cross hybrid of Citrus paradisi and Citrus tangerina (Rutaceae). Khelmarin D is found in citrus.
Egonol glucoside
Egonol glucoside is found in mushrooms. Egonol glucoside is produced by Laetiporus sulphureus var. miniatu Production by Laetiporus sulphureus variety miniatus. Egonol glucoside is found in mushrooms.
B-Trisaccharide
B-Trisaccharide in blood group B is formed and excreated due to given Galactose. The B-trisaccharide is the only oligosaccharide detected in plasma after oral galactose administration to a blood-group-B secretor individual. The concentration was 0.38 mg/l of plasma.(PMID: 510288). B-Trisaccharide in blood group B is formed and excreated due to given Galactose.
Fucosyllactose
Fucosyllactose is an oligosaccharide in human milk that may serve as an anti-inflammatory component and might therefore contribute to the lower incidence of inflammatory diseases in human milk-fed infants. (PMID 15583750) [HMDB] Fucosyllactose is an oligosaccharide in human milk that may serve as an anti-inflammatory component and might therefore contribute to the lower incidence of inflammatory diseases in human milk-fed infants. (PMID 15583750).
Blood group B trisaccharide
Tonapofylline
Cytidine-5'-diphosphocholine
D002491 - Central Nervous System Agents > D018697 - Nootropic Agents
Cistanoside F
Cistanoside F is a natural product found in Premna odorata, Cistanche deserticola, and other organisms with data available.
Echioidinin 2-(6-acetylglucoside)
4-acetoxymethyl-7-acetyl-4-<2-(6-acetyl-5-hydroxy-benzo furanyl)>-6-hydroxy-1-methylene-1,2,3,4-tetrahydrodibenzo furan|4-acetoxymethyl-7-acetyl-4-[2-(6-acetyl-5-hydroxy-benzo[b] furanyl)]-6-hydroxy-1-methylene-1,2,3,4-tetrahydrodibenzo[b,d] furan
3,4-di-O-[3-(4-hydroxyphenyl)propionyl]-1,5-dihydroxycyclohexanecarboxylic acid
2,3-Bis(2,4-dihydroxyphenyl)-2-[(3,5-dihydroxyphenyl)methyl]-2,3-dihydro-1H-indene-4,6-diol
2,3-isopropylidenequercitrin|2,3-isopropylidenequercitrin|Quercitrin derivative CPB-50-208-18
acacetin 7-O-(3-O-acetyl-beta-D-glucopyranoside)|acacetin-7-O-(3-acetyl)glucopyranoside
4-O-(beta-D-Glucopyranosyl)-3-O-(D-galactopyranosyl)-L-fucose
alpha-L-rhamnopyranosyl(1->4)-O-beta-D-glucopyranosyl(1->6)-beta-D-glucopyranoside
O-(4-O-trans-feruloyl-alpha-D-xylopyranosyl)-(1->6)-D-glucopyranose
alpha-L-rhamnopyranosyl-(1->3)-1-O-caffeoyl-beta-D-glucopyranoside
3,5-di-O-[3-(4-hydroxyphenyl)propionyl]-1,4-dihydroxycyclohexanecarboxylic acid
beta-D-Mannopyranosyl-(1鈥樏傗垎4)-alpha-D-galactopyranosyl-(1鈥樏傗垎4)-L-rhamnose
3-(beta-D-glucopyranosyloxy)-7-methoxy-5-(methoxycarbonyl)isoflavone|3-(beta-D-glucopyranosyloxy)-5-(7-methoxy-4-oxo-4H-1-benzopyran-3-yl)benzoic acid methyl ester|caragiside C
(E)-1-O-p-Feruloyl-beta-D-xylopyranosyl-(1->6)-beta-D-glucopyranose|1-O-Feruloyl-beta-D-xylopyranosyl-(1->6)-beta-D-glucopyranoside
(6-O-(E)-p-Coumaroyl)-??-D-fructofuranosyl-(2鈥樏傗垎1)-??-D-glucopyranoside|6-O-(E)-p-coumaroyl-beta-D-fructofuranosyl-(2->1)-alpha-D-glucopyranoside|6-O-p-coumaroyl-beta-D-fructofuranosyl alpha-D-glucopyranoside
2-O-(E)-caffeoyl-1-O-p-(E)-coumaroyl-beta-D-glucopyranose|2-O-(E)-Caffeoyl-1-O-p-(E)-coumaroyl-??-D-glucopyranose
kaempferide, 7-O-(4-O-acethyl-alpha-L-rhamnopyranosyl)
(+)-ent-grandifloracin|(+)-grandifloracin|gradifloracin|grandifloracin
(-)-methyl 3-methoxy-4-O-[6-O-(3-hydroxy-3-methylglutaryl)-beta-D-glucopyranosyl]benzoate|(-)-oplopanpheside A
6-O-apio-beta-furanosyl-[5-O-(trans-ferulic acid)]-alpha/beta-glucopyranoside
(2S)-5,7-dihydroxy-6,8-dimethyldihydroflavone-7-O-(6-O-acetyl)-beta-D-glucopyranoside
(3-O-cis-p-coumaroyl-beta-D-fructofuranosyl)-(2?1)-alpha-D-glucopyranoside|3-O-cis-p-coumaroylsucrose
5,7-dihydroxy-4-methoxyflavone-7-O-beta-D-(4-O-acetyl)glucopyranoside|acacetin-7-O-(4-acetyl)glucopyranoside
pectolinarigenin-7-O-beta-D-glucuronopyranoside methyl ester
(6S,7R,8R,14aR)-5,6,7,8-tetrahydro-3-methoxy-6,7-dimethyl-1,5-dioxo-1H-10,12,13-trioxabenzo[1,8]cycloocta[1,2,3-cd]-as-indacen-8-yl benzoate|kadsutherin C
venturamide A
An eighteen-membered homodetic cyclic peptide which is isolated from Oscillatoria sp. and exhibits antimalarial activity against the W2 chloroquine-resistant strain of the malarial parasite, Plasmodium falciparum.
alphaalpha-D-Glucopyranosyl-(1?3)-beta-D-galactopyranosyl-(1?2)-L-rhamnose
(2,5-dibenzoyloxy-1,6-dihydroxycyclohex-3-en-1-yl)methyl benzoate
(2,5-dibenzoyloxy-1,6-dihydroxycyclohex-3-en-1-yl)methyl benzoate
C21H28O13_(2E)-3-[4-({2-O-[(2S,3R,4R)-3,4-Dihydroxy-4-(hydroxymethyl)tetrahydro-2-furanyl]-beta-D-glucopyranosyl}oxy)-3-methoxyphenyl]acrylic acid
C21H28O13_alpha-D-Glucopyranoside, beta-L-fructofuranosyl 6-O-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]
C21H28O13_Hexopyranose, 2-O-hexopyranosyl-6-O-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]
(2,5-dibenzoyloxy-1,6-dihydroxycyclohex-3-en-1-yl)methyl benzoate [IIN-based: Match]
Cys Cys Thr Tyr
Cys Cys Tyr Thr
Cys Asp Asp His
Cys Asp His Asp
Cys Glu His Thr
Cys Glu Thr His
Cys Phe Gly Tyr
Cys Phe Tyr Gly
Cys Gly Phe Tyr
Cys Gly Tyr Phe
Cys His Asp Asp
Cys His Glu Thr
Cys His Thr Glu
Cys Thr Cys Tyr
Cys Thr Glu His
Cys Thr His Glu
Cys Thr Tyr Cys
Cys Tyr Cys Thr
Cys Tyr Phe Gly
Cys Tyr Gly Phe
Cys Tyr Thr Cys
Asp Cys Asp His
Asp Cys His Asp
Asp Asp Cys His
Asp Asp His Cys
Asp Glu Glu Pro
Asp Glu Pro Glu
Asp His Cys Asp
Asp His Asp Cys
Asp His Met Ser
Asp His Ser Met
Asp Met His Ser
Asp Met Ser His
Asp Pro Glu Glu
Asp Ser His Met
Asp Ser Met His
Glu Cys His Thr
Glu Cys Thr His
Glu Asp Glu Pro
Glu Asp Pro Glu
Glu Glu Asp Pro
Glu Glu Pro Asp
Glu His Cys Thr
Glu His Thr Cys
Glu Pro Asp Glu
Glu Pro Glu Asp
Glu Thr Cys His
Glu Thr His Cys
Phe Cys Gly Tyr
Phe Cys Tyr Gly
Phe Gly Cys Tyr
Phe Gly Tyr Cys
Phe Tyr Cys Gly
Phe Tyr Gly Cys
Gly Cys Phe Tyr
Gly Cys Tyr Phe
Gly Phe Cys Tyr
Gly Phe Tyr Cys
Gly Tyr Cys Phe
Gly Tyr Phe Cys
His Cys Asp Asp
His Cys Glu Thr
His Cys Thr Glu
His Asp Cys Asp
His Asp Asp Cys
His Asp Met Ser
His Asp Ser Met
His Glu Cys Thr
His Glu Thr Cys
His Met Asp Ser
His Met Ser Asp
His Ser Asp Met
His Ser Met Asp
His Thr Cys Glu
His Thr Glu Cys
Met Asp His Ser
Met Asp Ser His
Met His Asp Ser
Met His Ser Asp
Met Ser Asp His
Met Ser His Asp
Pro Asp Glu Glu
Pro Glu Asp Glu
Pro Glu Glu Asp
Ser Asp His Met
Ser Asp Met His
Ser His Asp Met
Ser His Met Asp
Ser Met Asp His
Ser Met His Asp
Thr Cys Cys Tyr
Thr Cys Glu His
Thr Cys His Glu
Thr Cys Tyr Cys
Thr Glu Cys His
Thr Glu His Cys
Thr His Cys Glu
Thr His Glu Cys
Thr Tyr Cys Cys
Tyr Cys Cys Thr
Tyr Cys Phe Gly
Tyr Cys Gly Phe
Tyr Cys Thr Cys
Tyr Phe Cys Gly
Tyr Phe Gly Cys
Tyr Gly Cys Phe
Tyr Gly Phe Cys
Tyr Thr Cys Cys
3-Fucosyllactose
A trisaccharide that is lactose in which the hydroxy group at position 3 of the glucosyl moiety has undergone formal condensation with the anomeric hydroxy group of fucose (6-deoxy-L-galactose) to give the corresponding glycoside. Found in human milk.
2-Fucosyllactose
2'-Fucosyllactose (2'-FL) is an oligosaccharide that could be derived from human milk. 2'-Fucosyllactose regulates the expression of CD14, alleviates colitis and regulates the gut microbiome. 2'-Fucosyllactose stimulates T cells to increase IFN-γ production and decreases IL-6, IL-17, and TNF-α production of cytokines[1][2].
B-Trisaccharide
Bisosthenon B
Egonol glucoside
6-O-Acetylglycitin
6''-O-Acetylglycitin, a acetyl glucoside, is one of the isoflavone isomer in soybeans, shows various extents of content reduction dependent on storage temperature, packaging condition, and its isoflavone isomer kind[1]. 6''-O-Acetylglycitin, a acetyl glucoside, is one of the isoflavone isomer in soybeans, shows various extents of content reduction dependent on storage temperature, packaging condition, and its isoflavone isomer kind[1].
Khelmarin D
Tipifarnib
C471 - Enzyme Inhibitor > C2020 - Farnesyl Transferase Inhibitor D000970 - Antineoplastic Agents
4-NITROPHENYL 2-ACETAMIDO-2-DEOXY--4-O-A-L-FUCOPYRANOSYL)-B-D-GLUCOPYRANOSIDE
N-[2-[(2-chloro-4,6-dinitrophenyl)azo]-5-(diallylamino)-4-methoxyphenyl]acetamide
5-(2-carboxyphenyl)-5-hydroxy-1-((2,2,5,5-tetramethyl-1-oxypyrrolidin-3-yl)-methyl)-3-phenyl-2-pyrrolin-4-one, potassium salt
Ilorasertib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D000970 - Antineoplastic Agents
2(1H)-Quinolinone, 6-(amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methyl-
D000970 - Antineoplastic Agents
alpha-D-Galp-(1->4)-beta-D-Galp-O(CH2)2S(CH2)2CO2Me
A glycoside that consists of alpha-D-galactosyl-(1->4)-beta-D-galactose having a 2-(2-methoxycarbonylethylthio)ethyl (CETE) moiety attached to the reducing end anomeric centre.
3-[[(Methylamino)sulfonyl]amino]-2-oxo-6-phenyl-n-[3,3,3-trifluoro-1-(1-methylethyl)-2-oxophenyl]-1(2h)-pyridine acetamide
(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-[hydroxy-[(4-nitrophenyl)methoxy]methyl]sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
(2,5-Dibenzoyloxy-1,6-dihydroxycyclohex-3-en-1-yl)methyl benzoate
O-1,4-alpha-L-Dihydrostreptosyl-streptidine 6-phosphate
alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl(1->2)]-D-galactose
6-[3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl]-3-(2,5-dimethoxyphenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine
(2E)-3-[4-({2-O-[(2S,3R,4R)-3,4-Dihydroxy-4-(hydroxymethyl)tetrahydro-2-furanyl]-beta-D-glucopyranosyl}oxy)-3-methoxyphenyl]acrylic acid
alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-beta-D-galactose
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]benzenesulfonamide
beta-D-Glcp-(1->4)-alpha-L-Rhap-(1->3)-beta-D-Glcp
3-{(3E)-3-[2-(2,4-dinitrophenyl)hydrazinylidene]-1-phenylbutyl}-4-hydroxy-2H-chromen-2-one
4-[3-[(3-chlorophenyl)methyl]-7-oxo-2H-triazolo[4,5-d]pyrimidin-5-yl]-N-(3-cyanophenyl)-1-piperidinecarboxamide
6-deoxy-L-galacto-hexopyranosyl-(1->2)-beta-D-galacto-hexopyranosyl-(1->4)-D-gluco-hexopyranose
(2S,3S,4R,5S,6S)-2-[(2R,3R,4R,5R,6R)-2,3-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-4-yl]oxy-6-methyloxane-3,4,5-triol
beta-L-rhamnosyl-(1->4)-beta-D-glucosyl-(1->4)-beta-D-galactose
1-[[2-Chloro-6-(4-methoxyphenoxy)phenyl]methyl]-3-(4-phenylmethoxyphenyl)urea
N-[[(4R,5R)-8-[2-(4-fluorophenyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide
N-[[(4S,5S)-8-[2-(4-fluorophenyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide
N-[[(4S,5R)-8-[2-(4-fluorophenyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-(2-morpholin-4-yl-2-oxoethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]benzenesulfonamide
N-[[(4R,5S)-8-[2-(4-fluorophenyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide
N-[[(4R,5S)-8-[2-(4-fluorophenyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide
N-[[(4S,5S)-8-[2-(4-fluorophenyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide
N-[[(4S,5R)-8-[2-(4-fluorophenyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide
N-[[(4R,5R)-8-[2-(4-fluorophenyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]benzenesulfonamide
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]benzenesulfonamide
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-(2-morpholin-4-yl-2-oxoethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]benzenesulfonamide
ethyl (2E)-2-[4-(acetyloxy)benzylidene]-7-methyl-3-oxo-5-[(E)-2-phenylethenyl]-2,3-dihydro-5H-[1,3]thiazolo[3,2-a]pyrimidine-6-carboxylate
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]benzenesulfonamide
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]benzenesulfonamide
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]benzenesulfonamide
2-[(3R,8Z,11S)-3-(4-chlorophenyl)-5,12-dioxo-1-oxa-4-azacyclododec-8-en-11-yl]-N-[(4-chlorophenyl)methyl]acetamide
4-deoxy-beta-D-mannopyranosyl-(1->2)-beta-D-mannopyranosyl-(1->2)-beta-D-mannopyranose
beta-D-mannopyranosyl-(1->2)-beta-D-mannopyranosyl-(1->2)-4-deoxy-beta-D-mannopyranose
alpha-L-Rhap-(1->3)-beta-D-Glcp-(1->4)-alpha-D-Glcp
(3E)-2-(4-Chloroanilino)-5-(4-chlorophenyl)-3-isopropylimino-phenazin-1-OL
3,4,5-trihydroxy-6-[4-[(E)-2-[2,3,5-trihydroxy-4-[(E)-3-methylbut-1-enyl]phenyl]ethenyl]phenoxy]oxane-2-carboxylic acid
6-[4-[(E)-2-[3,5-dihydroxy-4-[(E)-3-hydroxy-3-methylbut-1-enyl]phenyl]ethenyl]phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
3,4,5-trihydroxy-6-[3-hydroxy-2-[(E)-4-hydroxy-3-methylbut-1-enyl]-5-[(E)-2-(4-hydroxyphenyl)ethenyl]phenoxy]oxane-2-carboxylic acid
[1-[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-propanoyloxypropan-2-yl] hexanoate
[1-Butanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] pentanoate
[1-Acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] heptanoate
6-[(S)-amino-(4-chlorophenyl)-(3-methyl-4-imidazolyl)methyl]-4-(3-chlorophenyl)-1-methyl-2-quinolinone
glycitein 7-(6-O-acetyl-beta-D-glucoside)
A glycosyloxyisoflavone that is glycitin carrying an acetyl substituent at position 6 on the glucose moiety.
egonol beta-D-glucoside
A beta-D-glucoside that is egonol in which the hydroxy hydrogen has been replaced by a beta-D-glucosyl residue.
{3,5,6-trihydroxy-4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}methyl 3-(3,4-dihydroxyphenyl)prop-2-enoate
(1s,2r,3r,4r,7r,12s,13r,14r,15s,17r,19s,20r)-15-(furan-3-yl)-3,4,13,20-tetrahydroxy-2,7,14,20-tetramethyl-6,11,18-trioxahexacyclo[10.8.0.0²,¹⁰.0³,⁷.0¹⁴,¹⁹.0¹⁷,¹⁹]icos-9-ene-5,8-dione
5,6-dihydroxy-2-(hydroxymethyl)-4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-3-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate
4,5-dihydroxy-2-{[5-hydroxy-2-(4-methoxyphenyl)-4-oxochromen-7-yl]oxy}-6-(hydroxymethyl)oxan-3-yl acetate
(1r,6s,7s,8s)-7-(4-hydroxyphenyl)-1-[(1e)-2-(4-hydroxyphenyl)ethenyl]-4-methoxy-8-(4-methoxy-6-oxopyran-2-yl)-2-oxabicyclo[4.2.0]oct-4-en-3-one
11-ethylidene-7-hydroxy-7,14-dimethyl-2-methylidene-3,12-dioxo-4,13,17-trioxatetracyclo[8.6.1.0¹,⁵.0¹⁰,¹⁴]heptadec-5-en-16-yl 2-[(acetyloxy)methyl]prop-2-enoate
(1r,3ar,4r,6as)-1-(6-methoxy-2h-1,3-benzodioxol-5-yl)-4-[(6-methoxy-2h-1,3-benzodioxol-5-yl)oxy]-tetrahydro-1h-furo[3,4-c]furan-3a-yl acetate
2-[1-(2,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)ethyl]-5-[(1e)-2-(2,4-dihydroxyphenyl)ethenyl]benzene-1,3-diol
methyl (2s,3s,4r,5r,6s)-4,5-dihydroxy-6-{[5-hydroxy-2-(4-methoxyphenyl)-4-oxochromen-7-yl]oxy}-3-methoxyoxane-2-carboxylate
4-[1-(2,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)ethyl]-6-[2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,3-diol
(9s,10r)-10-({2,2-dimethyl-8-oxopyrano[3,2-g]chromen-5-yl}oxy)-9-hydroxy-8,8-dimethyl-9h,10h-pyrano[2,3-h]chromen-2-one
6-{[3,5-dihydroxy-2-(4-methoxyphenyl)-4-oxochromen-7-yl]oxy}-4,5-dihydroxy-2-methyloxan-3-yl acetate
11-{1-chloro-1,6,6-trimethyl-8-oxo-2,7-dioxaspiro[4.5]dec-9-en-3-yl}-6-(furan-3-yl)-7,11-dimethyl-2,5-dioxatricyclo[5.4.0.0¹,³]undec-9-en-4-one
methyl (5s,6r,7s)-5,6,9-trihydroxy-3,7-dimethoxy-6-[(2s)-3-methoxy-5-oxo-2h-furan-2-yl]-1-methyl-8-oxo-5,7-dihydroanthracene-2-carboxylate
[(2r,3s)-6-[3-(acetyloxy)prop-1-en-1-yl]-2,3-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-8-methoxy-4h-1-benzopyran-3-yl]methyl acetate
methyl 2-{[(3s)-5,7-dihydroxy-3-methoxy-6-methyl-1-oxo-3h-2-benzofuran-4-yl]oxy}-4-methoxy-3-[(1e)-3-methoxy-3-oxoprop-1-en-1-yl]-6-methylbenzoate
10-({8,8-dimethyl-2-oxopyrano[2,3-f]chromen-5-yl}oxy)-9-hydroxy-8,8-dimethyl-9h,10h-pyrano[2,3-h]chromen-2-one
methyl 2-[(2r,4r,6s,10s,12s,13s)-10,13-bis(acetyloxy)-4,15-dimethyl-8-oxo-3,7,17-trioxatetracyclo[12.2.1.1⁶,⁹.0²,⁴]octadeca-1(16),9(18),14-trien-12-yl]prop-2-enoate
2-[(1r)-1-(2,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)ethyl]-5-[(1e)-2-(2,4-dihydroxyphenyl)ethenyl]benzene-1,3-diol
1-O-feruloyl-β-D-xylopyranosyl-(1→6)-β-D-glucopyraboside
{"Ingredient_id": "HBIN002903","Ingredient_name": "1-O-feruloyl-\u03b2-D-xylopyranosyl-(1\u21926)-\u03b2-D-glucopyraboside","Alias": "NA","Ingredient_formula": "C21H28O13","Ingredient_Smile": "COC1=C(C=CC(=C1)C=CC(=O)OC2C(C(C(C(O2)COC3C(C(C(CO3)O)O)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "37116","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5-[3''-β-d-glucopyranosyloxy)propyl]-7-me-thoxy-2-(3',4'-methylenedioxyphenyl)benzo-furan
{"Ingredient_id": "HBIN011006","Ingredient_name": "5-[3''-\u03b2-d-glucopyranosyloxy)propyl]-7-me-thoxy-2-(3',4'-methylenedioxyphenyl)benzo-furan","Alias": "NA","Ingredient_formula": "C25H28O10","Ingredient_Smile": "COC1=C2C(=CC(=C1)CCCOC3C(C(C(C(O3)CO)O)O)O)C=C(O2)C4=CC5=C(C=C4)OCO5","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "8708","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(6-o-(e)-p-coumaroyl)-β-d-fructofuranosyl-(2→1)-α-d-glucopyranoside
{"Ingredient_id": "HBIN012671","Ingredient_name": "(6-o-(e)-p-coumaroyl)-\u03b2-d-fructofuranosyl-(2\u21921)-\u03b1-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C21H28O13","Ingredient_Smile": "C1=CC(=CC=C1C=CC(=O)OCC2C(C(C(O2)(CO)OC3C(C(C(C(O3)CO)O)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4159","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
alboctalol
{"Ingredient_id": "HBIN015083","Ingredient_name": "alboctalol","Alias": "NA","Ingredient_formula": "C28H24O8","Ingredient_Smile": "C1C(C(C(C2=C1C=C(C=C2O)O)C3=C(C=C(C=C3)O)O)C4=CC(=CC(=C4)O)O)C5=C(C=C(C=C5)O)O","Ingredient_weight": "488.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14222","TCMID_id": "863","TCMSP_id": "NA","TCM_ID_id": "7049","PubChem_id": "101204172","DrugBank_id": "NA"}
andalasin A
{"Ingredient_id": "HBIN016000","Ingredient_name": "andalasin A","Alias": "andalasin a","Ingredient_formula": "C28H24O8","Ingredient_Smile": "C1=CC(=C(C=C1O)O)C=CC2=CC(=C(C(=C2)O)C(CC3=CC(=CC(=C3)O)O)C4=C(C=C(C=C4)O)O)O","Ingredient_weight": "488.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "38447","TCMSP_id": "NA","TCM_ID_id": "19531","PubChem_id": "44576243","DrugBank_id": "NA"}